Equities Pharmaceuticals & Health
-
UBS no longer bullish on GSK
-
Analysts say AstraZeneca has ‘turned a corner’
-
AstraZeneca shares rise as pharmco returns to growth
1194 News
Close
Oops! You had already voted for this argument.
0
Brokers added for comparison:
Clear all